BioAge Labs News, BioAge Labs Quote, BIOA Quote

BioAge Labs (NQ:BIOA) Delayed: 22.32 +0.85 (3.96%)

Prev. Close

$21.47

Today 6M 1Y 5Y

Open

$20.90

52 Wk High

$8.73

52 Wk Low

$2.86

Day High

$22.45

Day Low

$20.61

P/E

N/A

EPS

$-3.82

Volume

498,065

Friends, Peers and Foes (?): B, BIOA-B.ST, BIOAB, BIOA-B, BIOAB.ST (more...)

ALERTS | RSS

Jun 22, 2026 01:53 AM BioArctic and Lilly sign research and collaboration agreement combining Lilly compound with BioArctic's BrainTransporter™ technology
Jun 16, 2026 08:00 AM BioAge Labs begins Phase 2 trial of NLRP3 inhibitor BGE-102
Jun 16, 2026 08:00 AM BioAge Labs Announces First Participant Dosed in QUELL-CV, a Phase 2 Proof-of-Concept Trial of BGE-102, a Novel Oral NLRP3 Inhibitor, in Patients at Elevated Cardiovascular Risk
Jun 12, 2026 04:37 PM Form 4 BioAge Labs, Inc. For: Jun 10 Filed by: Pande Vijay Satyanand
Jun 12, 2026 04:36 PM Form 4 BioAge Labs, Inc. For: Jun 10 Filed by: Hemrajani Rekha
Jun 12, 2026 04:34 PM Form 4 BioAge Labs, Inc. For: Jun 10 Filed by: HEALY JAMES
Jun 12, 2026 04:33 PM Form 4 BioAge Labs, Inc. For: Jun 10 Filed by: ENRIGHT PATRICK G
Jun 12, 2026 04:32 PM Form 4 BioAge Labs, Inc. For: Jun 10 Filed by: Davidson Michael H.
Jun 12, 2026 04:29 PM Form 4 BioAge Labs, Inc. For: Jun 10 Filed by: GARNIER JEAN PIERRE
Jun 12, 2026 08:00 AM Form 8-K BioAge Labs, Inc. For: Jun 10

Entities mentioned with BIOA

View All Entities